UBS AM’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,795
| Closed | -$270K | – | 2721 |
|
|
2024
Q3 | $270K | Buy |
9,795
+165
| +2% | +$4.55K | ﹤0.01% | 2742 |
|
|
2024
Q2 | $279K | Buy |
9,630
+7,980
| +484% | +$231K | ﹤0.01% | 2730 |
|
|
2024
Q1 | $73.6K | Hold |
1,650
| – | – | ﹤0.01% | 2500 |
|
|
2023
Q4 | $64K | Hold |
1,650
| – | – | ﹤0.01% | 2535 |
|
|
2023
Q3 | $48.5K | Buy |
+1,650
| New | +$48.5K | ﹤0.01% | 2581 |
|